Procter & Gamble Hygiene and Health Care share price today

Procter & Gamble Hygiene and Health Care Ltd's share price was ₹6,959.00 at the close on 4 November 2026. It has been falling for 102 weeks. That is 24.5% below its average price over the last 200 trading days.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Procter & Gamble Hygiene and Health Care Ltd is in stage 4. The phase helps read everything below.

In the last 52 weeks it traded between ₹6,639 and ₹13,174, and at that close it sat 5% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 57 weeks running.

Over the last 11 years the share price moved +11% while the NIFTY 500 moved +251%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 24 October 2025. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Three changes stood out: lowest operating margin in 8 quarters, indian funds and insurers (DIIs) cut their stake for 4 quarters in a row and number of shareholders up 29% in a year.

1. Lowest operating margin in 8 quarters

   Operating margin was 19% in the June 2026 quarter, against 28% a year earlier.

2. Indian funds and insurers (DIIs) cut their stake for 4 quarters in a row

   From 16.1% to 15% of the company by the September 2026 quarter.

3. Number of shareholders up 29% in a year

   64,415 shareholders in the September 2026 quarter, against 49,997 a year earlier.

Procter & Gamble Hygiene and Health Care paid ₹230 a share in regular dividends in the 12 months to 5 November 2026 (2 payments), a yield of 3.31% at the ₹6,959.00 close on 4 November 2026. The last was a dividend of ₹60 a share, ex-date 1 September 2026.

Procter & Gamble Hygiene and Health Care dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date.

Yes. Procter & Gamble Hygiene and Health Care Ltd paid out 97% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years.

From the NSE corporate-actions record, read 5 November 2026.

For April to June 2026 (the quarter ended 30 June 2026), Procter & Gamble Hygiene and Health Care reported revenue of ₹891 crore, down 4.9% from ₹937 crore a year earlier, and a profit of ₹126 crore, down 34.4% from ₹192 crore.

Procter & Gamble Hygiene and Health Care results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Procter & Gamble Hygiene and Health Care closed at ₹6,959.00 on 4 November 2026, down 47.2% from ₹13,174.00 a year earlier (7 November 2025) and down 51.7% over five years. Its highest weekly close since March 2016 was ₹18,427.55 on 17 November 2023.

Procter & Gamble Hygiene and Health Care share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

560 weekly closes from 11 March 2016 to 4 November 2026.

4 Nov 2026: Procter & Gamble Hygiene and Health Care closed at ₹6,959.00, up 1.6% on the week and up 4.8% on the month. 1 Sep 2026: ex-date for a dividend of ₹60 a share.

Earlier

• Results for April to June 2026: Revenue down 4.9% and profit down 34.4% on a year earlier.
• 5 Feb 2026: ex-date for an interim + special dividend of ₹195 a share.

Procter & Gamble Hygiene and Health Care is on 3 of our India lists: 52 week high & low, Dividend stocks and Small & mid cap stocks.

Procter & Gamble Hygiene and Health Care Ltd earned ₹126 Cr of net profit in the Jun 2026 quarter, −34.4% on the same quarter a year earlier. Full-year Mar 2026 profit was ₹856 Cr. Over 10 years profit has grown 7.3% a year on average. That is 14.1% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned ₹192 Cr.

Why profit moved: revenue changed −4.9% on a year earlier and the margin moved −9.0 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed −6.3% and revenue −1.9%. Profit is growing slower than sales: rising costs are taking part of the growth.

Procter & Gamble Hygiene and Health Care Ltd reported ₹891 Cr of revenue in the Jun 2026 quarter, −4.9% on the same quarter a year earlier. Over 10 years it has grown 6.5% a year on average. The last full year, Mar 2026, came in at ₹4,290 Cr. The last four reported quarters add to ₹4,244 Cr.

Revenue is everything the company billed its customers in the period.

Mar 2026 revenue was ₹4,290 Cr, +27.1% on the year before.

Recent pace: the last four quarters grew −1.9% on average, against 6.5% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew −1.6%, against +0.5% a year over the last 8 quarters (stabilising); profit over the last 12 months grew −4.7%, against +8.2% a year (rolling over).

Procter & Gamble Hygiene and Health Care Ltd's operating margin was 19.0% in the Jun 2026 quarter, 9.0 percentage points lower than the same quarter a year ago. Across 13 years it has been between 20.0% and 29.0%. The latest quarter is below every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −9.3 percentage points on the year while gross margin changed −6.2 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 92% of Procter & Gamble Hygiene and Health Care Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In Mar 2026 it brought in ₹924 Cr of operating cash against ₹856 Cr of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

After ₹49.0 Cr of spending on assets, ₹875 Cr was left over as free cash.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 92% of profit came in as cash: the cash cycle got 18 days longer between FY21 and Mar 2026, so more of each rupee of profit waits in the business before it arrives.

What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets.

Procter & Gamble Hygiene and Health Care Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was −126 days in Mar 2026, up from −144 days in FY21. It spent ₹122 Cr on assets over the last 3 years. Customers take 21 days to pay, and stock sits for 51 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At Mar 2026 sales of ₹4,290 Cr, each day of that cycle ties up about ₹11.8 Cr, so roughly −₹1,481 Cr is tied up in the business at any time.

Mar 26: customers took 21 days to pay and stock sat for 51 days, about 1.7 months of sales sitting as stock, for a full cycle of −126 days, longer than FY21's −144.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 51 days. Customers pay about 21 days after that. Suppliers are paid at 197 days. Together that makes the −126-day cycle.

Spending on assets: ₹122 Cr over the last 3 years, against ₹151 Cr of depreciation (the yearly wear and tear on existing assets). So it is spending about what it takes to replace what wears out, or less. Work still in progress is ₹21.0 Cr (Mar 2026): assets paid for that are not earning yet.

In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean.

Procter & Gamble Hygiene and Health Care Ltd's P/E is 28.5×, about the lowest it has ever been. Its usual P/E (the middle reading) is 72.6×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.